Twenty two patients (19 females) with focal nodular hyperplasia were seen between 1973 and 1989. Five were children, and all the adults were aged under 42 years (median 33 years). Fourteen patients (64%) were symptomatic on presentation. Twelve of the 14 adult women had taken the oral contraceptive pill. Twelve patients, nine of whom were symptomatic, underwent hepatic resection shortly after presentation. There were no deaths or major complications, and all remain well on follow up. Four patients underwent either hepatic artery embolisation or ligation. After an interval of six to 10 years they were asymptomatic and only one has histological evidence of residual focal nodular hyperplasia. Of five patients initially treated conservatively, two were asymptomatic and have remained so for three and 13 years. One of the three symptomatic patients became symptom free after stopping the contraceptive pill. The management of focal nodular hyperplasia requires a flexible approach. Lesions which are asymptomatic can be observed with regular ultrasound and treated if they enlarge or become symptomatic. Symptomatic patients who present while taking the contraceptive pill can also have a trial of conservative treatment. Other symptomatic patients, including those who previously took the pill, are best treated by surgical resection, and, where this is not possible, by embolisation.
Focal nodular hyperplasia of the liver is a rare benign lesion that occurs predominantly in women during their reproductive years. Previously it was referred to by a variety of names until Edmondson' introduced the term 'focal nodular hyperplasia' in 1958. It consists of a well circumscribed region ofhyperplastic liver parenchyma often containing a stellate fibrous scar. Most reported cases have presented as incidental findings,2-' and the aetiology and natural history of this condition remain largely unknown. Consequently, the correct choice of management is unclear. In this study we have reviewed our experience of 22 patients with this condition as the basis of formulating a plan of management.
Patients and methods
Between 1973 and 1989, 22 patients (19 females and three males) with focal nodular hyperplasia were seen at King's College Hospital. Details of the patients are given in the Table. There were five children. All adults were aged under 42 years (median 33 years). Fourteen patients (64%) presented with either pain or a mass. In the remaining eight patients focal nodular hyperplasia was an incidental finding at laparotomy (three), on an abdominal examination (two), on an abdominal ultrasound (one), in a resected liver specimen separate from fibrolamellar carcinoma (one), and as an incidental finding at necropsy in a 13 year old girl with von Gierke's disease (type I glycogen storage disease) who had died during a portocaval shunt procedure. Focal nodular hyperplasia was situated in the right hepatic lobe in 16 patients, in the left lobe in three patients, across the interlobular plane in two patients, and in both lobes in one patient. Histological confirmation offocal nodular hyperplasia was obtained in all patients. Eight patients did not undergo resection offocal nodular hyperplasia and in these the diagnosis was made by open biopsy in five and by Trucut needle biopsy in three.
Results
Twelve of the 14 adult females had at some time taken the oral contraceptive pill. None took it after the diagnoses of focal nodular hyperplasia was made.
Twelve of the 22 patients, nine of whom were symptomatic with pain or a mass, underwent hepatic resection shortly after presentation. One further symptomatic patient (case 13) was initially treated conservatively but the symptoms continued and he underwent resection three years after diagnosis. There were no deaths or major postoperative complications. All As it has been suggested that focal nodular hyperplasia is a hyperplastic response of the hepatic parenchyma to a pre-existing arterial malformations 1 ' embolisation or hepatic ligation may seem a logical option in the management. ' We have treated four patients in this way (one of whom has been reported previously6), but have been able to find only one other published case treated similarly.29 Apart from a pronounced but temporary fever, the procedures have been uncomplicated. All four patients have had a reduction in the size of the lesion and, when present, symptom relief. One has been shown subsequently to have histological evidence of focal nodular hyperplasia, and two others still have abnormal scans. Hepatic resection is the preferred treatment for most symptomatic lesions, but when contraindicated or surgically not possible embolisation may be a suitable alternative. For small lesions superselective embolisation can be performed' and this will minimise the degree of hepatic ischaemia to the remainder of the hepatic lobe.
The management of focal nodular hyperplasia requires a flexible approach. Asymptomatic lesions can be observed safely with regular ultrasound, and treated if they become symptomatic or enlargement occurs. Patients presenting with symptomatic lesions while taking the contraceptive pill can also have a course of conservative treatment. Other symptomatic patients, including those with a previous history of taking the contraceptive pill, are best treated by surgical resection, and, where not possible, by embolisation.
